NPM1 and acute myeloid leukemia: NPM1 mutations in AML are further classified based on the number of the lost tryptophan residues: the mutations causing the loss of two tryptophan residues are characterized as A-like, in contrast to those inducing the loss of one tryptophan residue, which are characterized as non-A-like, more extensively studied in pediatric AML [18].